Senait Forst Selected Research

Human Regular Insulin (Humulin)

1/2010

Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Senait Forst Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 01/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2006 - 05/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2014
1	Diabetes Mellitus 03/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2014
1	Insulin Resistance 01/2012

Drug/Important Bio-Agent (IBA)

2	Retinaldehyde (Retinal)IBA 03/2014 - 01/2012
2	Insulin Lispro (Humalog)FDA Link 01/2010 - 05/2005
2	Insulin (Novolin)FDA Link 01/2010 - 05/2005
1	Human Regular Insulin (Humulin)IBA 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 04/2006
1	Blood Glucose (Blood Sugar)IBA 04/2006